Thomas Schulze

Thomas Schulze is the Founder & CEO of FundaMental Pharma, a start-up focused on developing neuroprotective small molecules. With a background in biopharmaceuticals and molecular genetics, Schulze has held various leadership roles in companies such as EirGenix, Navibion, and Avontec GmbH. Thomas also has experience in gene therapy, autoimmune research, and virology. Schulze holds a Ph.D. in HIV replication and retrovirology from the Max Planck Institute for Molecular Genetics.